Literature DB >> 1459452

Initiation on chromatin templates in a yeast RNA polymerase II transcription system.

Y Lorch1, J W LaPointe, R D Kornberg.   

Abstract

Templates were prepared with either the TATA box or transcription start sites of the yeast CYC1 promoter in a nucleosome. In both cases, initiation in an unfractionated yeast RNA polymerase II transcription system was abolished by the nucleosome. The inhibition appeared to be relieved by the activator protein Gal4-VP16 binding to a site upstream of the promoter. Inhibition was not relieved, however, in a transcription system reconstituted from purified components, indicating a requirement for additional factors for the effect of Gal4-VP16.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459452     DOI: 10.1101/gad.6.12a.2282

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  17 in total

Review 1.  Human genetic variation within neural crest enhancers: molecular and phenotypic implications.

Authors:  Alvaro Rada-Iglesias; Sara L Prescott; Joanna Wysocka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-05-06       Impact factor: 6.237

2.  Activation domain-mediated enhancement of activator binding to chromatin in mammalian cells.

Authors:  C A Bunker; R E Kingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

3.  TTF-I determines the chromatin architecture of the active rDNA promoter.

Authors:  G Längst; P B Becker; I Grummt
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nucleosome cores.

Authors:  M Vettese-Dadey; P Walter; H Chen; L J Juan; J L Workman
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

5.  Direct activation and anti-repression functions of GAL4-VP16 use distinct molecular mechanisms.

Authors:  J G Lyons; P Chambon
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

6.  Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II.

Authors:  C Brou; A Kuhn; A Staub; S Chaudhary; I Grummt; I Davidson; L Tora
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

7.  Isolation of the yeast histone octamer.

Authors:  Y Lorch; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.

Authors:  P L Sheridan; T P Mayall; E Verdin; K A Jones
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

9.  Mutations that suppress the deletion of an upstream activating sequence in yeast: involvement of a protein kinase and histone H3 in repressing transcription in vivo.

Authors:  G Prelich; F Winston
Journal:  Genetics       Date:  1993-11       Impact factor: 4.562

10.  Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression.

Authors:  J J Caterina; D J Ciavatta; D Donze; R R Behringer; T M Townes
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.